GILTLOT® Tab 75mg contains Clopidogrel USP 75mg, an antiplatelet medicine belonging to the P2Y12 platelet inhibitor class. It is prescribed to help reduce the risk of blood-clot-related cardiovascular events, including heart attack and stroke, in certain patients with acute coronary syndrome, recent myocardial infarction, recent stroke, or established peripheral arterial disease.

Manufactured by Glitz Pharma, GILTLOT® Tab 75mg is supplied in a pack of 30 tablets, as shown on the product packaging. It should be used only according to the instructions of a qualified healthcare professional.

\n

Prescription Medicine: Clopidogrel affects platelet function and can increase the risk of bleeding. Do not start, stop, or change the dose without medical advice.

\n

Purpose

GILTLOT® Tab 75mg may be prescribed for:

\n
• Acute Coronary Syndrome (ACS)
\n
• Recent Myocardial Infarction (Heart Attack)
\n
• Recent Ischemic Stroke
\n
• Established Peripheral Arterial Disease (PAD)
\n
• Reduction of the risk of certain heart attacks and strokes
\n
• Other cardiovascular conditions as determined by a healthcare professional
\n

\n

Note: Approved indications and treatment recommendations may vary by country. Always follow your physician's advice and local prescribing information.

\n

Key Features

\n
• Contains Clopidogrel USP 75mg
\n
• P2Y12 platelet inhibitor / antiplatelet medicine
\n
• Prescription medicine
\n
• Pack contains 30 Tablets
\n
• Manufactured by Glitz Pharma
\n
• Oral tablet formulation
\n
• Used to help prevent certain blood-clot-related cardiovascular events
\n

Benefits

\n
• Helps reduce platelet aggregation and blood clot formation.
\n
• May reduce the risk of heart attack and stroke in appropriate patients.
\n
• Used in the management of certain acute coronary syndromes.
\n
• May be prescribed following certain heart attacks or ischemic strokes.
\n
• May be used in patients with established peripheral arterial disease.
\n
• Convenient 75mg oral tablet formulation.
\n

Pros

\n
• Contains the established antiplatelet ingredient Clopidogrel.
\n
• 75mg is an established maintenance strength for several approved indications.
\n
• Helps provide protection against platelet-related blood clot formation when appropriately prescribed.
\n
• Convenient once-daily dosing is used for several approved indications.
\n
• Available in a 30-tablet pack.
\n
• Manufactured by Glitz Pharma.
\n

Cons

\n
• Can increase the risk of bleeding or bruising.
\n
• Not suitable for people with active pathological bleeding, such as certain gastrointestinal or intracranial bleeding.
\n
• May interact with certain medicines, including omeprazole and esomeprazole.
\n
• Effectiveness can be reduced in patients with certain CYP2C19 genetic variations.
\n
• Should not be discontinued without medical advice, particularly after certain cardiovascular procedures or events.
\n
• Not appropriate for every patient and requires professional medical assessment.
\n

Active Ingredient

Clopidogrel USP 75mg

Dosage Form

Tablets

Pack Size

30 Tablets

Drug Class

Antiplatelet / P2Y12 Platelet Inhibitor

Manufacturer

Glitz Pharma

Storage Instructions

\n
• Store according to the manufacturer's recommended storage conditions.
\n
• Keep in a cool, dry place.
\n
• Protect from excessive heat, moisture, and direct sunlight.
\n
• Keep out of the reach of children.
\n
• Keep tablets in their original packaging until use.
\n
• Do not use after the expiry date printed on the package.
\n

Precautions

\n
• Use only under the supervision of a qualified healthcare professional.
\n
• Inform your doctor if you have a history of bleeding, stomach ulcers, or other bleeding disorders.
\n
• Tell your healthcare provider about all medicines and supplements you are taking.
\n
• Do not stop clopidogrel without consulting your doctor.
\n
• Inform your doctor before surgery, dental procedures, or other invasive procedures.
\n
• Avoid taking omeprazole or esomeprazole with clopidogrel unless your healthcare professional specifically advises otherwise, because these medicines can reduce clopidogrel's antiplatelet activity.
\n
• Seek medical attention for unusual or persistent bleeding, black stools, blood in urine, or other signs of significant bleeding.
\n
• Take the medicine exactly as prescribed; the appropriate regimen depends on the medical condition being treated.
\n

Product Specifications